Lv4
750 积分 2024-02-12 加入
Staging of astrocytopathy and complement activation in neuromyelitis optica spectrum disorders
4小时前
待确认
CFHR2 Supplementation Mitigates Pathologies of Neuromyelitis Optica by Regulating Complement Activation
4小时前
已完结
Exosome-mediated co-delivery of superoxide dismutase and chondroitinase ABC for multiple sclerosis therapy
5小时前
已完结
Efficacy and Safety of Rituximab for New-Onset Generalized Myasthenia Gravis
19天前
已完结
Rituximab in AChR subtype of myasthenia gravis: systematic review
19天前
已完结
CFHR2 Supplementation Mitigates Pathologies of Neuromyelitis Optica by Regulating Complement Activation
1个月前
已完结
Myasthenia gravis: subgroup classification and therapeutic strategies
1个月前
已完结
FcRn: the neonatal Fc receptor comes of age
1个月前
已完结
New treatment strategies in Myasthenia gravis
1个月前
已完结
Safety, efficacy, and tolerability of efgartigimod in patients with generalised myasthenia gravis (ADAPT): a multicentre, randomised, placebo-controlled, phase 3 trial
1个月前
已完结
皖公网安备34019202002308
